Growth Metrics

Emergent BioSolutions (EBS) Long-Term Debt Issuances (2020 - 2025)

Emergent BioSolutions (EBS) has 7 years of Long-Term Debt Issuances data on record, last reported at $154.0 million in Q3 2024.

  • For Q3 2024, Long-Term Debt Issuances changed N/A year-over-year to $154.0 million; the TTM value through Jun 2025 reached $154.0 million, up 136.92%, while the annual FY2024 figure was $219.0 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $154.0 million in Q3 2024 per EBS's latest filing, up from $15.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $154.0 million in Q3 2024 and bottomed at -$450.0 million in Q4 2020.
  • Average Long-Term Debt Issuances over 3 years is -$93.8 million, with a median of $15.0 million recorded in 2024.